Markers of nutritional status and inflammation in transthyretin cardiac amyloidosis: association with outcomes and the clinical phenotype
- 11 December 2019
- journal article
- research article
- Published by Taylor & Francis in Amyloid
- Vol. 27 (2) , 73-80
Abstract
Background: Patients with transthyretin (TTR) cardiac amyloidosis demonstrate cardiac cachexia with progression of their cardiomyopathy, which is characterised by malnutrition and a heightened inflammatory state. How best to measure this condition is less well characterised. We investigated differences in survival among patients with ATTR cardiac amyloidosis by nutritional status as defined by modified BMI (mBMI) and by inflammatory state as defined by serum uric acid. Methods and results: This study was a retrospective analysis of patients diagnosed with ATTR cardiac amyloidosis at a single tertiary medical centre. Baseline characteristics were compared by nutritional status as measured by mBMI and by inflammatory state as measured by serum uric acid. Kaplan-Meier survival analyses were used to compare nutritional status and inflammatory status for the composite outcome of death. Cox proportional hazards modelling was used to assess predictors of death in this cohort. Three hundred patients (mean age 75 ± 11) years, 84.3% male) were included. Those with low mBMI (8.8 mg/dL) had shorter time to death (4.9 vs. 7.7 years, log rank p < .0001). Those with both low mBMI and elevated serum uric acid had the shortest time to death (4.3 years, log rank p = .005). In this cohort, mBMI was not a univariate predictor of death though there was a trend towards significance (HR 0.92, per 100 kg/m2 g/L, 95% CI 0.828–1.016, p = .099). Serum uric acid was a univariate predictor of death (HR 1.27 per 1 mg/dL, 95% CI 1.114–1.455, p < .001). In multivariate Cox analysis, this association remained significant (HR 1.31 per 1 mg/dL increase, 95% CI 1.096–1.560, p = .003) as well as in a separate stepwise model controlling for potential confounders including daily diuretic use, uric acid lowering therapy, and renal dysfunction. Conclusions: Both nutritional status as measured by mBMI and inflammation as measured by serum uric acid are associated with survival in patients with TTR cardiac amyloidosis however only serum uric acid is an independent predictor of death.Keywords
This publication has 31 references indexed in Scilit:
- A reduction of BMI predicts the risk of rehospitalization and cardiac death in non-obese patients with heart failureInternational Journal of Cardiology, 2019
- Meta-Analysis of the Relation of Body Mass Index to All-Cause and Cardiovascular Mortality and Hospitalization in Patients With Chronic Heart FailureThe American Journal of Cardiology, 2015
- Impact of Obesity and the Obesity Paradox on Prevalence and Prognosis in Heart FailureJACC: Heart Failure, 2013
- Body mass index and mortality in heart failure: A meta-analysisAmerican Heart Journal, 2008
- Vascular Oxidative Stress and Endothelial Dysfunction in Patients With Chronic Heart FailureCirculation, 2002
- PRETRANSPLANT CACHEXIA AND MORBID OBESITY ARE PREDICTORS OF INCREASED MORTALITY AFTER HEART TRANSPLANTATION1Transplantation, 2001
- Uric acid in cachectic and noncachectic patients with chronic heart failure: Relationship to leg vascular resistanceAmerican Heart Journal, 2001
- Uric acid in chronic heart failure: a marker of chronic inflammationEuropean Heart Journal, 1998
- Wasting as independent risk factor for mortality in chronic heart failureThe Lancet, 1997
- Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathyJournal of Internal Medicine, 1994